STOCKHOLM, March 18 (Reuters) - A previously healthy woman
has died in Sweden about a week after being vaccinated with the
AstraZeneca vaccine, the Swedish Medical Products Agency said on
Thursday.
"This is a case of blood clots in the arteries and veins and
major bleeding, ie the unusual disorder that is the focus of the
EMA investigation," Veronica Arthurson, head of drug safety at
the Swedish Medical Products Agency, told a news conference.
Sweden on Thursday said it would extend the its pause of the
AstraZeneca vaccine until next week.
EU's drug watchdog said on Thursday it is still convinced
the benefits of AstraZeneca's COVID-19 vaccine outweigh
the risks following an investigation into reports of blood clots
that prompted more than a dozen nations to suspend its use.
(Reporting by Johan Ahlander
Editing by Chizu Nomiyama)